Aandelen in “Fabricage van farmaceutische preparaten”

Aandeel Datum Koers Evolutie
vlag Lannett Co., Inc. 16/06 0,030 USD
+1,19% 		+1,19%
vlag Lantern Pharma Inc 20/05 5,820 USD
-3,48% 		-3,48%
vlag Larimar Therapeutics Inc 20/05 7,270 USD
-1,49% 		-1,49%
vlag Leap Therapeutics Inc 20/05 2,570 USD
-2,28% 		-2,28%
vlag Legend Biotech Corp 20/05 45,430 USD
+0,60% 		+0,60%
vlag Lexicon Pharmaceuticals Inc 20/05 1,770 USD
0,00% 		0,00%
vlag Lifevantage Corporation 20/05 7,180 USD
+5,90% 		+5,90%
vlag Ligand Pharmaceuticals, Inc. 20/05 86,630 USD
+0,66% 		+0,66%
vlag Lipocine Inc 20/05 6,370 USD
+5,46% 		+5,46%
vlag Lumos Pharma Inc 20/05 2,620 USD
+3,15% 		+3,15%

Nieuws over “Fabricage van farmaceutische preparaten”

20/05 · Sanofi: Information concerning the total number of voting rights and shares - April 2024 · Persbericht

20/05 · Sanofi: Information concerning the total number of voting rights and shares - April 2024 · Persbericht

20/05 · Insmed Presents Positive Patient-Reported Outcomes and Microbiologic Data from Phase 3 ARISE Study Of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with NTM Lung Disease Caused by MAC at American Thoracic Society 2024 International Conference Plenary Session · Persbericht

20/05 · Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM · Persbericht

20/05 · Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics' COVID-19 Vaccine · Persbericht

20/05 · Soligenix Encourages Stockholders to Vote Prior to Annual Meeting · Persbericht

20/05 · PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation · Persbericht

17/05 · BioLineRx Announces Receipt of Nasdaq Minimum Bid Price Notification · Persbericht

17/05 · AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week® · Persbericht

17/05 · Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules · Persbericht

17/05 · AKRO Investors: Reminder - Important Deadline in Securities Fraud Class Action Lawsuit Akero Therapeutics, Inc. · Persbericht

16/05 · Galapagos creates new subscription right plans · Persbericht

16/05 · Galapagos creëert nieuwe inschrijvingsrechtenplannen · Persbericht

16/05 · Moleculin Abstract Accepted for Poster Presentation at the European Hematology Association (EHA) 2024 Hybrid Congress · Persbericht

16/05 · Regulus Therapeutics Announces Promotion of Rekha Garg, M.D., M.S., to Chief Medical Officer · Persbericht

16/05 · Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis · Persbericht

16/05 · Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice · Persbericht

16/05 · Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, a Novel HER2-Targeting CAR-Monocyte · Persbericht

16/05 · Ionis announces positive topline results from Phase 1/2a trial of ION582 for Angelman syndrome · Persbericht

16/05 · With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin · Persbericht

15/05 · Galapagos gaat kankertherapie produceren in Amerikaanse bloedcentra · Tijd.be (€)

Het beursgenoteerde Mechelse biotechbedrijf Galapagos gaat samenwerken met Blood Centers of America, het grootste Amerikaanse bloedvoorzieningsnetwerk, om er lokaal zijn gepersonaliseerde kankerbehand...

Mijn selecties